Chemed Corporation (CHE) Hit 52-Week High at $332.05 on May, 16

May 16, 2018 - By Michael Lund

Big Money Sentiment decreased to 0.96 in 2017 Q4. It has change of 0.08, from 2017Q3’s 1.04. The ratio fall due to Chemed Corporation positioning: 18 sold and 94 reduced. 49 funds amassed positions and 58 increased positions. Investors holded 15.40 million in 2017Q3 but now own 14.86 million shares or 3.45% less.
Rockefeller Finance Inc holds 0.36% or 94,789 shs in its capital. Royal Bancorporation Of Canada reported 0% in Chemed Corporation (NYSE:CHE). 59,784 were reported by Prudential Fin. Great Lakes Advsrs Ltd Liability Company holds 0.12% of its capital in Chemed Corporation (NYSE:CHE) for 21,811 shs. Gam Holdg Ag invested in 2,967 shs or 0.02% of the stock. Strs Ohio holds 0.01% or 7,100 shs in its capital. Eagle Boston Inv holds 65,916 shs. Numeric Llc holds 0.12% of its capital in Chemed Corporation (NYSE:CHE) for 68,400 shs. Aperio Group Ltd Liability Com reported 0.02% of its capital in Chemed Corporation (NYSE:CHE). Stephens Ar invested in 0.01% or 1,179 shs. Legal And General Grp Public Ltd holds 0.01% of its capital in Chemed Corporation (NYSE:CHE) for 33,320 shs. Mutual Of America Cap Mgmt Ltd Liability Corp owns 19,482 shs for 0.07% of their capital. Tiaa Cref Management Lc has 78,494 shs. California Pub Employees Retirement Sys holds 70,182 shs or 0.02% of its capital. Schwab Charles Mngmt has 109,134 shs for 0.02% of their capital.

Chemed Corporation registered $27.86 million net activity with 0 buys and 13 selling transactions since January 12, 2018. Another trade for 1,000 shs valued at $313,000 was made by Witzeman Michael D on Wednesday, May 2. $428,257 worth of Chemed Corporation (NYSE:CHE) shs were sold by LEE SPENCER S. Another trade for 22,000 shs valued at $6.59M was made by MCNAMARA KEVIN J on Tuesday, April 24. On Monday, May 7 WILLIAMS DAVID PATRICK also sold $3.16M worth of Chemed Corporation (NYSE:CHE). On Wednesday, May 2 a trade for 12,919 shs valued at $4.04 million was made by Westfall Nicholas Michael. On Tuesday, April 24 Shares for $91,476 were sold by Dallob Naomi C.

Today Chemed Corporation (NYSE:CHE) with $332.05 stock price, reached yearly high with $355.29 PT or 7.00 % above. On May, 16 it was reported by Barchart.com. Chemed Corporation (NYSE:CHE) has $5.29B MC. At $355.29 PT, the company’s valuation could be $370.44M more.

Ticker’s shares touched $332.05 during the last trading session after 1.72% change.Chemed Corporation has volume of 105,172 shares. Since May 16, 2017 CHE has risen 48.33% and is uptrending. CHE outperformed by 36.78% the S&P 500.

Investors wait Chemed Corporation (NYSE:CHE)’s quarterly earnings on July, 24., Faxor reports. Analysts forecast $2.68 earnings per share. That’s $0.53 up or 24.65 % from 2017’s earnings of $2.15. If $2.68 is reported, CHE’s profit will be $42.71 million for 30.97 P/E. -1.47 % negative EPS growth is what Wall Street’s forecasts after $2.72 reported EPS last quarter.

More recent Chemed Corporation (NYSE:CHE) news were brought out by Seekingalpha.com, Benzinga.com and Globenewswire.com. The first one has “Chemed’s (CHE) CEO Kevin McNamara on Q1 2018 Results – Earnings Call Transcript” as a title and was brought out on April 20, 2018. The next is “Earnings Scheduled For April 19, 2018” on April 19, 2018. And last was brought out on May 07, 2018, called “VITAS HEALTHCARE JOINS AMERICAN HOSPITAL ASSOCIATION”.

Chemed Corporation provides hospice and palliative care services in the United States.The company has $5.29 billion market cap. It operates through two divisions, VITAS and Roto-Rooter.The P/E ratio is 56.66. The firm offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.

Chemed Corporation (NYSE:CHE) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: